NSC | Compound | Enrichment | Correlation |
---|---|---|---|
NSC 762149 | N-(4-{2-[(1R,6R,11aS,13S,14aR)-1,13-dihydroxy-4-oxo-1,6,7,8,9,11a,12,13,14,14a-decahydro-4H-cyclopenta[f]oxacyclotridecin-6-yl]ethyl}phenyl)acetamide | 0.0287337488682928 | -0.011763965 |
NSC 762934 | Null | 0.0287337488682928 | 0.11782278 |
NSC 83715 | Null | 0.0287337488682928 | -0.16222233 |
NSC 9358 | 2-[[p-(dimethylamino)phenyl]azo]pyridine | 0.0287337488682928 | 0.059547523 |
NSC 113951 | 6-Bromotoyocamycin | 0.0287337488682932 | 0.075323547 |
NSC 116878 | Cardiac glycoside | 0.0287337488682932 | 0.31307894 |
NSC 123978 | Sarveroside | 0.0287337488682932 | 0.33198683 |
NSC 13317 | Null | 0.0287337488682932 | 0.033473518 |
NSC 180198 | Hydrazinecarbothioamide, 2,2'-(1,5-dimethyl-1,5-pentanediylidene)bis[N-methyl- | 0.0287337488682932 | 0.035888068 |
NSC 274548 | Gold, [.mu.-[[5,5'-methylenebis[1H-tetrazolato]](2-)-N(1):N(1')]]bis(triphenylphosphine)di- | 0.0287337488682932 | -0.17989876 |